Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1426 to 1450 of 1921 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
887 Inhibition, NADH-ubiquinone oxidoreductase (complex I)
1 Cellular Nov 29, 2016 Oct 3, 2025
885 Increase, Cancer
1 Tissue Nov 29, 2016 Aug 22, 2023
881 Increased, Triglyceride
1 Cellular Nov 29, 2016 Sep 16, 2017 61: NFE2L2/FXR activation leading to hepatic steatosis
880 Increased, ApoB100
1 Tissue Nov 29, 2016 Sep 16, 2017 61: NFE2L2/FXR activation leading to hepatic steatosis
879 Activation, MTTP
1 Cellular Nov 29, 2016 Sep 16, 2017 61: NFE2L2/FXR activation leading to hepatic steatosis
878 Inhibition, SREBP1c
1 Molecular Nov 29, 2016 Sep 16, 2017 61: NFE2L2/FXR activation leading to hepatic steatosis
877 Inhibition, organic anion transporter 1 (OAT1)
1 Molecular Nov 29, 2016 Sep 16, 2017 138: Organic anion transporter (OAT1) inhibition leading to renal failure and mortality
876 Increase, Mutations in Critical Genes
1 Molecular Nov 29, 2016 Sep 16, 2017
875 Binding of agonist, Ionotropic glutamate receptors
1 Molecular Nov 29, 2016 Sep 16, 2017
872 Increase, Site of Contact Nasal Tumors
1 Organ Nov 29, 2016 Sep 16, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
870 Increase, Cell Proliferation
2 Cellular Nov 29, 2016 Dec 10, 2024
869 Increase, Respiratory or Squamous Metaplasia
1 Tissue Nov 29, 2016 Sep 29, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
868 Increase, Tissue Degeneration, Necrosis & Atrophy
2 Tissue Nov 29, 2016 Sep 16, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
867 Decrease, Intracellular pH
1 Cellular Nov 29, 2016 Sep 16, 2017 136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
864 Decreased, Body Weight
1 Individual Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
863 Increased, Catabolism of Muscle Protein
1 Organ Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
862 Not Increased, Circulating Ketone Bodies
2 Tissue Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
861 Decreased, Ketogenesis (production of ketone bodies)
1 Cellular Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
860 Decreased, Mitochondrial Fatty Acid Beta Oxidation
1 Molecular Nov 29, 2016 Sep 16, 2017 318: Glucocorticoid Receptor activation leading to hepatic steatosis
859 Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids
1 Molecular Nov 29, 2016 Sep 16, 2017 None
858 Decreased, PPARalpha transactivation of gene expression
1 Molecular Nov 29, 2016 Apr 30, 2019 6: Antagonist binding to PPARα leading to body-weight loss
857 Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain
0 Molecular Nov 29, 2016 Nov 29, 2016 None
856 Formation, Hepatocellular and Bile duct tumors
2 Organ Nov 29, 2016 Sep 16, 2017 41: Sustained AhR Activation leading to Rodent Liver Tumours
854 Alterations, Cellular proliferation / hyperplasia
3 Tissue Nov 29, 2016 Sep 16, 2017
853 Changes/Inhibition, Cellular Homeostasis and Apoptosis
2 Cellular Nov 29, 2016 Sep 16, 2017 41: Sustained AhR Activation leading to Rodent Liver Tumours